PT  - JOURNAL ARTICLE
AU  - Horve, Patrick F.
AU  - Dietz, Leslie
AU  - Fretz, Mark
AU  - Constant, David A.
AU  - Wilkes, Andrew
AU  - Townes, John M.
AU  - Martindale, Robert G.
AU  - Messer, William B.
AU  - Van Den Wymelenberg, Kevin G.
TI  - Identification of SARS-CoV-2 RNA in Healthcare Heating, Ventilation, and Air Conditioning Units
AID  - 10.1101/2020.06.26.20141085
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.26.20141085
4099  - http://medrxiv.org/content/early/2020/06/28/2020.06.26.20141085.short
4100  - http://medrxiv.org/content/early/2020/06/28/2020.06.26.20141085.full
AB  - Available information on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmission by small particle aerosols continues to evolve rapidly. To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where Coronavirus Disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of samples taken from nine different locations in multiple air handlers. While samples were not evaluated for viral infectivity, the presence of viral RNA in air handlers raises the possibility that viral particles can enter and travel within the air handling system of a hospital, from room return air through high efficiency MERV-15 filters and into supply air ducts. Although no known transmission events were determined to be associated with these specimens, the findings suggest the potential for HVAC systems to facilitate transmission by environmental contamination via shared air volumes with locations remote from areas where infected persons reside. More work is needed to further evaluate the risk of SARS-CoV-2 transmission via HVAC systems and to verify effectiveness of building operations mitigation strategies for the protection of building occupants. These results are important within and outside of healthcare settings and may present a matter of some urgency for building operators of facilities that are not equipped with high-efficiency filtration.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research benefited from the University of Oregon and Oregon Health and Science University seed research funds and the Oregon Health and Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Environmental sampling does not require Institutional Review Board (IRB) approval; however, the project was reviewed by the OHSU IRB and an IRB Exemption was granted for this work.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available upon request.